Ex Parte Tsai et al - Page 9


                 Appeal No.  2007-0056                                                          Page 9                   
                 Application No.  09/906,511                                                                             
                        Kosako addresses the problem of “spurious particles” by measuring the                            
                 number of particles in the relevant size ranges “before four or more insoluble                          
                 carriers can be aggregated. . . .”  Kosako, column 5, lines 47-61.  While ‘211 and                      
                 ‘978 do not speak to “spurious particles”, appellants have not explained why the                        
                 PIDS measurement technique could not be used to measure a “spurious particle”                           
                 in a sample “before four or more insoluble carriers can be aggregated,” as set                          
                 forth in Kosako.  Contrary, to appellants’ argument, we find no evidence on this                        
                 record to suggest that particle measurement by PIDS could not be used in place                          
                 of the device exemplified by Kosako.                                                                    
                        Lastly, appellants assert that their claimed invention has an unexpected                         
                 advantage over “conventional light-scattering methods” because “the PIDS                                
                 methodology . . . provides a more sensitive means in detecting small changes in                         
                 the scattering pattern when compared to conventional techniques.”  Brief,                               
                 bridging paragraph, pages 6-7.  According to appellants (Brief, page 7), Kosako                         
                 does not mention PIDS at all, and ‘211 and ‘978 do not recognize this advantage                         
                 because they “do no suggest application of the technique to analyte detection in                        
                 particle-enhanced assays to increase sensitivity.”  We disagree.                                        
                        As set forth in In re Freeman, 474 F.2d 1318, 1324, 177 USPQ 139, 143                            
                 (CCPA 1973):                                                                                            
                        In order for a showing of “unexpected results” to be probative                                   
                        evidence of non-obviousness, it falls upon the applicant to at least                             
                        establish: (1) that there actually is a difference between the results                           
                        obtained through the claimed invention and those of the prior art;                               
                        and (2) that the difference actually obtained would not have been                                
                        expected by one skilled in the art at the time of the invention.                                 







Page:  Previous  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  Next

Last modified: September 9, 2013